BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 8, 2008
View Archived Issues
Ahead of OncoGenex Merger, Sonus Adds Caspase Program
Read More
Compliance in Off-Label and Journal Articles
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More
Celgene Calls it Quits in GPC Satraplatin Deal
Celgene Corp. has ended its nearly three-year partnership with embattled German firm GPC Biotech AG on its prostate cancer drug satraplatin. (BioWorld Today)
Read More
Acorda's $114M Offering to Support NDA, Launch
Read More